Eli Lilly, Sanofi Beat Antitrust Suit Alleging Insulin Conspiracy
A New York federal judge on Thursday tossed an antitrust suit alleging major drug manufacturers conspired to retract insulin discounts to boost profits, saying the companies developed their drug policies separately...To view the full article, register now.
Already a subscriber? Click here to view full article